Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON21964
NL-OMON21964
Recruiting
Not Applicable

Autologous blood transfusion after total knee arthroplasty

A/Orbis0 sites750 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTKA, transfusion, blood, autoloog

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
TKA, transfusion, blood, autoloog
Sponsor
A/Orbis
Enrollment
750
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
A/Orbis

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing primary TKA
  • •\- Surgery between January 2010 and December 2011

Exclusion Criteria

  • •\- Secondary total knee arthroplasty
  • •\- Rheumatoid arthritis (RA)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
se of stem cells which have capacity to grow to liver cells in patients of cirrhosis of liver who have jaundice, ascites( water in abdomen)
CTRI/2017/11/010429Asian Healthcare Foundation
Completed
Not Applicable
Autologous Blood Transfusion After Local InfiltrationTotal Hip ArthroplastyTotal Knee Arthroplasty
NCT01576263Northern Orthopaedic Division, Denmark52
Completed
Not Applicable
Blood transfusion in lower limb arthroplasty: the safe and economical futureSurgery: Primary knee arthroplastySurgeryPrimary knee arthroplasty
ISRCTN24531848Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)120
Completed
Not Applicable
Are autotransfusion drains effective for total knee arthroplasty? A randomised controlled trial
ISRCTN65166542Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
JPRN-UMIN000026084agoya University Graduate School of Medicine10